Show 20 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Hamadani, Mehdi" or (type any "bookEditor issueEditor" and editor="Hamadani, Mehdi") Add to list Conference Paper C3 Safety profile and clinical response to MEDI-551, a humanized monoclonal anti-CD19, in a phase 1/2 study in adults with relapsed or refractory advanced B-cell malignancies Andres Forero-Torres, Mehdi Hamadani, Michelle A Fanale, Celeste M Bello, Thomas J Kipps, Fritz Offner (UGent) , Gregor Verhoef, Massimo Federico, Stephanie A Gregory, Anne Sonet, et al. (2013) BLOOD. 122(21). Add to list Conference Paper C3 SAR245409 Monotherapy in relapsed/refractory follicular lymphoma: preliminary results from the phase II ARD12130 study Jennifer R Brown, Mehdi Hamadani, Jon Arnason, Lionel Karlin, John Hayslip, Nina Wagner-Johnston, Guillaume Cartron, Vincent Ribrag, Sophie de Guibert, Stephen Opat, et al. (2013) BLOOD. 122(21).